These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

903 related items for PubMed ID: 15932438

  • 1. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M, Gibbs P, Tjandra J, Cullinan M, McLaughlin S, Faragher I, Skinner I, Jones I.
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [Abstract] [Full Text] [Related]

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 3. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1098-105. PubMed ID: 15519780
    [Abstract] [Full Text] [Related]

  • 4. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ.
    Dis Colon Rectum; 2004 Dec 15; 47(12):2025-31. PubMed ID: 15657650
    [Abstract] [Full Text] [Related]

  • 5. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A, Mukhopadhyay T, Ramani VS, Perkins K, Snee AJ, Jelley F, Wong H, Lee CD.
    Colorectal Dis; 2010 Aug 15; 12 Suppl 2():30-6. PubMed ID: 20618365
    [Abstract] [Full Text] [Related]

  • 6. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
    Marsh RD, Chu NM, Vauthey JN, Mendenhall WM, Lauwers GY, Bewsher C, Copeland EM.
    Cancer; 1996 Jul 15; 78(2):217-25. PubMed ID: 8673995
    [Abstract] [Full Text] [Related]

  • 7. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):665-77. PubMed ID: 15708244
    [Abstract] [Full Text] [Related]

  • 8. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH, Lee KC, Choi JH, Oh JH, Baek JH, Park SH, Shin DB.
    Jpn J Clin Oncol; 2008 Feb 01; 38(2):112-21. PubMed ID: 18263881
    [Abstract] [Full Text] [Related]

  • 9. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.
    Ann Surg; 2008 Aug 01; 248(2):243-51. PubMed ID: 18650634
    [Abstract] [Full Text] [Related]

  • 10. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M, Martínez-Monge R, García-Foncillas J, Azinovic I, Aristu J, López-García G, Brugarolas A.
    Gynecol Oncol; 1999 Jul 01; 74(1):30-7. PubMed ID: 10385548
    [Abstract] [Full Text] [Related]

  • 11. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K.
    Ann Surg Oncol; 2008 Dec 01; 15(12):3471-7. PubMed ID: 18846402
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA, Calvo FA, Cortés J, García-Sabrido JL, Gómez-Espí M, Del Valle E, Muñoz-Jiménez F, Alvarez E.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1122-8. PubMed ID: 16406393
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
    Movsas B, Diratzouian H, Hanlon A, Cooper H, Freedman G, Konski A, Sigurdson E, Hoffman J, Meropol NJ, Weiner LM, Coia L, Lanciano R, Stein J, Kister D, Eisenberg B.
    Am J Clin Oncol; 2006 Oct 15; 29(5):435-41. PubMed ID: 17023775
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W, Boterberg T, Pattyn P, van Eijkeren M, Gillardin JM, Demetter P, Smeets P, Van Damme N, Monsaert E, Peeters M.
    Ann Surg Oncol; 2007 Feb 15; 14(2):424-31. PubMed ID: 17096057
    [Abstract] [Full Text] [Related]

  • 19. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW, Jacobsen A, Qvortrup C, Hansen F, Bisgaard C, Baatrup G, Rasmussen P, Pfeiffer P.
    Acta Oncol; 2008 Feb 15; 47(3):428-33. PubMed ID: 18348002
    [Abstract] [Full Text] [Related]

  • 20. Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome.
    Prausová J, Lohynská R, Kubácková K, Linke Z, Malinová B, Kubala E, Novotný J.
    Neoplasma; 2006 Feb 15; 53(3):263-8. PubMed ID: 16652199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.